Search results :

Fondaparinux

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: B01AX05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Oedema Oedema uncommon, 8.66% - 8.8% x x x x x
Dermatitis Rash uncommon, 7.5% - 8.32% x x x x x x x x x
Rash Rash uncommon, 7.5% - 8.32% x x x x x x x x x
Eruption 2.58% - 3.1% x
Anaemia Anaemia uncommon — 0.272% - 19.6% 1.2% - 1.22% x x x x x x x x x
Gingival bleeding Gingival bleeding common x x
Insomnia Insomnia 0.917% - 5.41% 0.304% x x x x x x x
Postoperative wound infection Postoperative wound infection rare, 4.9% x x x x x x
Constipation Constipation rare, 1.8% - 10.5% 2.1% x x x x x
Wound secretion Wound discharge increased 0.612% - 4.65% 0% x x x x x x x
Wound secretion uncommon x x
Hypokalaemia Hypokalaemia rare, 0% - 4.2% 0% x x x x x x x x x
Dizziness Dizziness rare, 0.612% - 4.17% 0% x x x x x x x x x
Syncope rare x x
Purpura Purpura uncommon, 0% - 3.54% 0% x x x x x x x x x
Vascular purpura Purpura uncommon, 0% - 3.54% 0% x x x x x x x x x
Urinary tract infection Urinary tract infection 1.82% - 4% 4% x x x
Nausea Nausea uncommon, 0.3% - 12.2% 1.2% x x x x x
Body temperature increased Body temperature increased uncommon, 0.3% - 15.4% 1.2% - 4.44% x x x x x
Hypotension Hypotension rare, 0.306% - 3.5% 0% x x x x x x x x x
Confusional state Confusional state rare, 1.2% - 4.1% 0.3% - 0.304% x x x x x x x x x
Feeling abnormal Confusional state rare, 1.2% - 4.1% 0.3% - 0.304% x x x x x x x x x
Urinary retention Urinary retention 2.9% - 2.96% x x x
Haemoglobin decreased Haemoglobin decreased 1.89% - 3.86% x
Haematuria Haematuria uncommon, common x x
Haemoptysis Haemoptysis uncommon, common x x
Haematoma Haematoma uncommon — 1.2% - 2.85% 0.3% - 0.304% x x x x x x x x x
Dermatitis bullous Bullous eruption 0% - 3.1% 0.304% x x x x x x
Blister x x x x
Dyspepsia Dyspepsia rare, 2.4% - 2.58% x x x x x
Post procedural haemorrhage Postoperative hemorrhage common, 0.6% - 2.4% 0.6% - 0.608% x x x x x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased 0.305% - 4.27% x
Atrial fibrillation Atrial fibrillation 1.03% - 3.02% 2.02% x
Headache Headache rare, 1.43% - 4.53% 2.24% x x x x x
Diarrhoea Diarrhoea rare, 0.5% - 2.58% 2.4% x x x x x
Pain Pain 1.7% - 2.55% x x x
Contusion Contusion 1.05% - 2.18% x
Aspartate aminotransferase increased Aspartate aminotransferase increased 0.174% - 2.82% x x x x x
Chest pain Chest pain rare, 0.727% - 1.84% 1.49% x x x
Epistaxis Epistaxis uncommon, 1.09% - 1.31% x x x x x x x
Ventricular tachycardia Ventricular tachycardia 0.281% - 1.66% 1.03% x
Abdominal pain Abdominal pain rare, 1.27% - 1.44% x x x
Gastrointestinal pain Abdominal pain rare, 1.27% - 1.44% x x x
Vomiting Vomiting uncommon, 0.501% - 5.97% 1.2% - 1.49% x x x x x
Back pain Back pain 0.999% - 1.31% x
Procedural site reaction Surgical site reaction 0.7% - 1.5% 2.4% x
Haemorrhage Haemorrhage postmarketing — 0% - 5.02% 0% - 2.2% x x x x x x x x x
Haemoglobin Haemorrhage postmarketing — 0% - 5.02% 0% - 2.2% x x x x x x x x x
Pain in extremity Leg pain rare, 0.908% - 1.35% x x x
Prothrombin level decreased Prothrombin level decreased 0.272% - 1.31% x
Anxiety Anxiety rare, 0.727% - 0.785% x x x
Cough Cough rare, 0.636% - 2.09% x x x
Surgery Surgical intervention 0.391% - 0.782% x
Coagulopathy Coagulopathy uncommon x x
Pruritus Pruritus uncommon x x x x x x x x x
Oedema peripheral Oedema peripheral uncommon x x
Hepatic function abnormal Hepatic function abnormal uncommon, 0.436% - 1.27% x x x
Hepatic enzyme increased Hepatic enzyme increased uncommon, 0.305% - 4.72% x x x
Thrombocytosis Thrombocytosis uncommon x x
Cardiac tamponade Cardiac tamponade 0.35% - 0.543% 0.79% - 1.06% x
Dyspnoea Dyspnoea rare, uncommon x x
Haemorrhage intracranial Haemorrhage intracranial 0% - 0.131% x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing, rare x x x x
Angioedema Angioedema postmarketing, rare x x x x
Asthenia Fatigue rare x x
Fatigue Fatigue rare x x
Flushing Flushing rare x x
Gastritis Gastritis rare x x
Hyperbilirubinaemia Hyperbilirubinaemia rare x x
Hypersensitivity Hypersensitivity postmarketing, rare x x x x x x
Shock Syncope rare x x
Syncope Syncope rare x x
Loss of consciousness Syncope rare x x
Thrombocytopenia Thrombocytopenia postmarketing, uncommon x x x x x x x x x
Thrombosis Thrombosis postmarketing x x x x
Vertigo Vertigo rare x x
Oedema genital Oedema genital rare x x
Heparin-induced thrombocytopenia Heparin-induced thrombocytopenia postmarketing x x x x
Menopausal symptoms Hot flush rare x x
Hot flush Hot flush rare x x
Spinal haematoma Spinal haematoma postmarketing x
Somnolence Somnolence rare x x
Blister Blister x x x x
Infection Infection x x
Eye haemorrhage Eye haemorrhage x
Gastrointestinal disorder Gastrointestinal disorder x x
Cardiac arrest Cardiac arrest x
Cardiac failure Cardiac failure x
Immune system disorder Immune system disorder x x
Liver disorder Liver disorder x x x x x x
Hepatocellular injury Liver disorder x x x x x x
Foetor hepaticus Liver disorder x x x x x x
Mediastinal disorder Mediastinal disorder x x
Nervous system disorder Nervous system disorder x x
Angiopathy Angiopathy x x
Injection site haemorrhage Injection site haemorrhage x x x x x x x
Retroperitoneal haemorrhage Retroperitoneal haemorrhage 0% x x x x x x x
Malnutrition Malnutrition x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Hepatobiliary disease Hepatobiliary disease x x
Haemorrhagic stroke Haemorrhagic stroke x
Cerebral haemorrhage Haemorrhagic stroke x
Cerebral haemorrhage x x
Drug interaction Drug interaction x
Infestation Infestation NOS x x
Local reaction Local reaction x x x x x x
Acute coronary syndrome Acute coronary syndrome x
Thrombosis in device Catheter thrombosis x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FONDAPARINUX

Side effects:26
Source:FDA Structured Product Label

FONDAPARINUX

Side effects:29
Source:FDA Structured Product Label

FONDAPARINUX

Side effects:29
Source:FDA Structured Product Label

fondaparinux

Side effects:30
Source:FDA Structured Product Label

FONDAPARINUX SODIUM / ARIXTRA

Side effects:32
Source:FDA

Fondaparinux Sodium / Arixtra

Side effects:32
Source:FDA

FONDAPARINUX SODIUM / ARIXTRA

Side effects:56
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label